NASDAQ:ZYXI Zynex (ZYXI) Stock Forecast, Price & News $9.18 -0.13 (-1.40%) (As of 06/6/2023 ET) Add Compare Share Share Today's Range$9.11▼$9.4250-Day Range$9.18▼$14.5652-Week Range$6.65▼$17.25Volume169,300 shsAverage Volume323,885 shsMarket Capitalization$336.45 millionP/E Ratio20.40Dividend YieldN/APrice Target$19.63 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Zynex MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside113.8% Upside$19.63 Price TargetShort InterestBearish23.63% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth53.33%From $0.45 to $0.69 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.05 out of 5 starsMedical Sector346th out of 981 stocksElectromedical Equipment Industry7th out of 20 stocks 3.5 Analyst's Opinion Consensus RatingZynex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $19.63, Zynex has a forecasted upside of 113.8% from its current price of $9.18.Amount of Analyst CoverageZynex has only been the subject of 2 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted23.63% of the float of Zynex has been sold short.Short Interest Ratio / Days to CoverZynex has a short interest ratio ("days to cover") of 13.1, which indicates bearish sentiment.Change versus previous monthShort interest in Zynex has recently increased by 11.74%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldZynex does not currently pay a dividend.Dividend GrowthZynex does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ZYXI. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Zynex this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for ZYXI on MarketBeat in the last 30 days. This is a decrease of -93% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Zynex insiders have not sold or bought any company stock.Percentage Held by Insiders46.56% of the stock of Zynex is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 28.64% of the stock of Zynex is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Zynex are expected to grow by 53.33% in the coming year, from $0.45 to $0.69 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Zynex is 20.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 143.08.Price to Earnings Ratio vs. SectorThe P/E ratio of Zynex is 20.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 129.11.Price to Book Value per Share RatioZynex has a P/B Ratio of 5.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Zynex (NASDAQ:ZYXI) StockZynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. It also develops a new blood volume monitor for use in hospitals and surgery centers. The company was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.Read More Receive ZYXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter. Email Address ZYXI Stock News HeadlinesJune 2, 2023 | americanbankingnews.comAnalyzing Zynex (NASDAQ:ZYXI) and Precision Optics (NASDAQ:POCI)May 29, 2023 | finance.yahoo.comThose who invested in Zynex (NASDAQ:ZYXI) five years ago are up 214%June 7, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Software" to Revolutionize WarfareThis breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>May 16, 2023 | americanbankingnews.comZynex (NASDAQ:ZYXI) versus Hyperfine (NASDAQ:HYPR) Financial ReviewMay 5, 2023 | finance.yahoo.comAfter the recent decline, Zynex, Inc. (NASDAQ:ZYXI) CEO Thomas Sandgaard's holdings have lost 17% of their valueMay 4, 2023 | finance.yahoo.comZynex Prices Upsized $52.5 Million Convertible Senior Notes OfferingMay 4, 2023 | finance.yahoo.comZynex Announces Update Regarding Previously Announced OfferingsMay 3, 2023 | finance.yahoo.comZynex Announces Proposed $50 Million Offering of Convertible Senior NotesJune 7, 2023 | Behind the Markets (Ad)Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software"Denver firm proves its possible to use AI to save the lives of soldiers in combat. England, Germany, Japan and Australia have all signed contracts within the past 18 months. Get the name of the stock here >>>May 3, 2023 | finance.yahoo.comZynex Announces Proposed Secondary Public Offering of Common StockMay 3, 2023 | finance.yahoo.comZynex Named as a Winner of Colorado's Top Workplaces 2023 by The Denver PostMay 2, 2023 | americanbankingnews.comZynex (NASDAQ:ZYXI) Updates Q1 2023 Earnings GuidanceMay 2, 2023 | americanbankingnews.comZynex (NASDAQ:ZYXI) Updates FY 2023 Earnings GuidanceMay 2, 2023 | americanbankingnews.comBrokers Set Expectations for Zynex, Inc.'s Q2 2023 Earnings (NASDAQ:ZYXI)April 27, 2023 | finance.yahoo.comZynex Inc. (ZYXI) Beats Q1 Earnings and Revenue EstimatesApril 27, 2023 | finance.yahoo.comZynex Announces 2023 First Quarter EarningsApril 19, 2023 | finance.yahoo.comZynex, Inc. to Announce First Quarter 2023 Financial ResultsApril 16, 2023 | americanbankingnews.comZynex (NASDAQ:ZYXI) Stock Rating Reaffirmed by HC WainwrightApril 13, 2023 | finance.yahoo.comAn Intrinsic Calculation For Zynex, Inc. (NASDAQ:ZYXI) Suggests It's 44% UndervaluedApril 13, 2023 | americanbankingnews.comZynex (NASDAQ:ZYXI) Releases Q1 Earnings GuidanceApril 13, 2023 | msn.comHC Wainwright & Co. Reiterates Zynex (ZYXI) Buy RecommendationApril 12, 2023 | americanbankingnews.comZynex (NASDAQ:ZYXI) Issues FY23 Earnings GuidanceApril 11, 2023 | finance.yahoo.comZynex Reports Preliminary First Quarter 2023 ResultsApril 6, 2023 | finance.yahoo.comZynex Earns Spot on Financial Times List of "The Americas' Fastest-Growing Companies 2023" for Second Consecutive YearApril 3, 2023 | benzinga.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Zynex, Inc. Investors to Inquire About Class Action Investigation - ZYXIApril 3, 2023 | benzinga.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zynex, Inc. - ZYXIApril 1, 2023 | marketwatch.comROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Zynex, Inc. Investors to Inquire About Class Action Investigation - ZYXISee More Headlines ZYXI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZYXI Company Calendar Last Earnings4/27/2023Today6/07/2023Next Earnings (Estimated)7/26/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ZYXI CUSIPN/A CIK846475 Webwww.zynex.com Phone(303) 703-4906FaxN/AEmployees774Year FoundedN/APrice Target and Rating Average Stock Price Forecast$19.63 High Stock Price Forecast$28.00 Low Stock Price Forecast$12.50 Forecasted Upside/Downside+113.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.45 Trailing P/E Ratio20.40 Forward P/E Ratio20.40 P/E GrowthN/ANet Income$17.05 million Net Margins10.19% Pretax Margin12.89% Return on Equity26.02% Return on Assets14.91% Debt Debt-to-Equity Ratio0.06 Current Ratio3.09 Quick Ratio2.42 Sales & Book Value Annual Sales$158.17 million Price / Sales2.13 Cash Flow$0.54 per share Price / Cash Flow17.15 Book Value$1.77 per share Price / Book5.19Miscellaneous Outstanding Shares36,650,000Free Float19,588,000Market Cap$336.45 million OptionableOptionable Beta0.59 Key ExecutivesThomas SandgaardChairman, President & Chief Executive OfficerAnna LucsokChief Operating OfficerDaniel J. MoorheadChief Financial & Accounting OfficerSteve FoxVice President-SalesDave AnttilaDirector-Human ResourcesKey CompetitorsEdap TmsNASDAQ:EDAPAxoGenNASDAQ:AXGNHyperfineNASDAQ:HYPRViewRayNASDAQ:VRAYFONARNASDAQ:FONRView All CompetitorsInsiders & InstitutionsRoyce & Associates LPSold 8,029 shares on 5/23/2023Ownership: 0.194%Capital Impact Advisors LLCSold 30,764 shares on 5/23/2023Ownership: 0.137%Ameriprise Financial Inc.Sold 4,157 shares on 5/22/2023Ownership: 0.222%Anson Funds Management LPBought 333,200 shares on 5/19/2023Ownership: 0.000%JPMorgan Chase & Co.Bought 6,235 shares on 5/18/2023Ownership: 0.465%View All Insider TransactionsView All Institutional Transactions ZYXI Stock - Frequently Asked Questions Should I buy or sell Zynex stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ZYXI shares. View ZYXI analyst ratings or view top-rated stocks. What is Zynex's stock price forecast for 2023? 3 brokerages have issued twelve-month price objectives for Zynex's stock. Their ZYXI share price forecasts range from $12.50 to $28.00. On average, they expect the company's stock price to reach $19.63 in the next year. This suggests a possible upside of 113.8% from the stock's current price. View analysts price targets for ZYXI or view top-rated stocks among Wall Street analysts. How have ZYXI shares performed in 2023? Zynex's stock was trading at $13.91 at the start of the year. Since then, ZYXI stock has decreased by 34.0% and is now trading at $9.18. View the best growth stocks for 2023 here. When is Zynex's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023. View our ZYXI earnings forecast. How were Zynex's earnings last quarter? Zynex, Inc. (NASDAQ:ZYXI) posted its quarterly earnings data on Thursday, April, 27th. The company reported $0.04 EPS for the quarter, beating analysts' consensus estimates of $0.01 by $0.03. The business had revenue of $42.17 million for the quarter, compared to analyst estimates of $39.67 million. Zynex had a net margin of 10.19% and a trailing twelve-month return on equity of 26.02%. What ETFs hold Zynex's stock? ETFs with the largest weight of Zynex (NASDAQ:ZYXI) stock in their portfolio include Invesco S&P SmallCap 600 Pure Growth ETF (RZG), Hartford Multifactor Small Cap ETF (ROSC), First Trust Dow Jones Select Microcap Index Fund (FDM), Syntax Stratified SmallCap ETF (SSLY), Invesco DWA SmallCap Momentum ETF (DWAS), Barrons 400 ETF (BFOR), Invesco S&P SmallCap Health Care ETF (PSCH) and Invesco S&P SmallCap Momentum ETF (XSMO). What guidance has Zynex issued on next quarter's earnings? Zynex issued an update on its first quarter 2023 earnings guidance on Tuesday, May, 2nd. The company provided EPS guidance of 0-$0.03 for the period, compared to the consensus earnings per share estimate of $0.01. The company issued revenue guidance of $39.00 million-$41.00 million, compared to the consensus revenue estimate of $39.61 million. What is Thomas Sandgaard's approval rating as Zynex's CEO? 81 employees have rated Zynex Chief Executive Officer Thomas Sandgaard on Glassdoor.com. Thomas Sandgaard has an approval rating of 87% among the company's employees. What is Zynex's stock symbol? Zynex trades on the NASDAQ under the ticker symbol "ZYXI." Who are Zynex's major shareholders? Zynex's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.28%), State Street Corp (1.87%), Geode Capital Management LLC (1.19%), Anson Funds Management LP (0.00%), Anson Funds Management LP (0.00%) and Bank of New York Mellon Corp (0.74%). Insiders that own company stock include Anna Lucsok, Daniel J Moorhead and Thomas Sandgaard. View institutional ownership trends. How do I buy shares of Zynex? Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Zynex's stock price today? One share of ZYXI stock can currently be purchased for approximately $9.18. How much money does Zynex make? Zynex (NASDAQ:ZYXI) has a market capitalization of $336.45 million and generates $158.17 million in revenue each year. The company earns $17.05 million in net income (profit) each year or $0.45 on an earnings per share basis. How many employees does Zynex have? The company employs 774 workers across the globe. How can I contact Zynex? Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The official website for the company is www.zynex.com. The company can be reached via phone at (303) 703-4906 or via email at info@zynex.com. This page (NASDAQ:ZYXI) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.